Key facts
- This page summarizes Cheryl Ann Stouch's Form 4 filing for Keenova Therapeutics plc.
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Apr 2026, 20:00.
Cheryl Ann Stouch - 23 Apr 2026 Form 4 Insider Report for Keenova Therapeutics plc
- Reporting relationship
- EVP & Chief Info Officer
- Issuer ticker
- N/A
- Reported as of
- 23 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Apr 2026, 20:00:45 UTC
- Prior SEC filing
- 26 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Tyndall, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Cheryl Ann Stouch filed Form 4 for Keenova Therapeutics plc on 24 Apr 2026.
Change
- Previous filing in this sequence was filed on 26 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002077699
Primary reporting owner
Stouch Cheryl Ann
- Relationship
- EVP & Chief Info Officer
- Address
- 440 ROUTE 22 EAST, SUITE 302, BRIDGEWATER
- Signature
- /s/ Mark Tyndall, Attorney-in-Fact
- Signature date
- 24 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
No ticker
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +1,137
- Change %
- +180%
- Price
- Shares after
- 1,768
- Date
- 23 Apr 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No ticker
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -1,137
- Change %
- -4.3%
- Price
- $0.000000*
- Shares after
- 25,032
- Date
- 23 Apr 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 1,137
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each vested restricted stock unit ("RSU") was settled in one ordinary share of the Issuer.
Footnote F2
The RSUs, which were granted on September 30, 2024, vest ratably on April 23, 2025, April 23, 2026 and April 23, 2027.
SEC remarks
This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.